AJOVY (fremanezumab-vfrm) Patient Assistance Program
Don’t let the high cost of brand specialty CGRP migraine preventive therapy disrupt your treatment. We help eligible patients access Ajovy (fremanezumab-vfrm) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Ajovy (fremanezumab-vfrm) is FDA-approved for the preventive treatment of migraine in adults — both episodic and chronic migraine. It is an anti-CGRP monoclonal antibody given as a subcutaneous injection monthly or quarterly.
- Without assistance, Ajovy costs commonly run approximately $700–$900 per monthly injection (or $2,100–$2,700 for the quarterly 675 mg dose).
- Through AffordMyPrescriptions, qualifying patients can access Ajovy for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no biosimilar of Ajovy in the U.S. as of 2026. Other anti-CGRP/CGRP-receptor monoclonal antibodies for migraine prevention include erenumab (Aimovig, anti-CGRP receptor, SC monthly), galcanezumab (Emgality, SC monthly), and eptinezumab (Vyepti, IV quarterly). Oral CGRP receptor antagonists for prevention include atogepant (Qulipta) and rimegepant (Nurtec ODT — also for acute).
What Is Ajovy Prescription Assistance Program?
The Ajovy Prescription Assistance Program is a manufacturer-sponsored initiative that provides Ajovy at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for migraine prevention patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, neurology/primary care coordination, prior-authorization documentation (often requiring prior trial of preventive medications), specialty pharmacy logistics, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification.
Pharmacy Price Comparison
- Without assistance, Ajovy costs roughly $700–$900 per monthly injection. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$880/dose | Save ~$810/dose |
| CVS Pharmacy | ~$900/dose | Save ~$830/dose |
| Walmart | ~$740/dose | Save ~$670/dose |
| Costco | ~$720/dose | Save ~$650/dose |
Specialty Pharmacy | ~$760/dose | Save ~$690/dose |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Ajovy Prescription Program?
The Patient Assistance Program is free to apply for and provides Ajovy at no medication cost if approved. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Ajovy:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
- Still $700–$900/dose per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Ajovy assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Ajovy Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Ajovy:
Ajovy (fremanezumab-vfrm) is a humanized monoclonal antibody that binds and neutralizes calcitonin gene-related peptide (CGRP) — a key neuropeptide driving migraine attacks. It is used for the preventive treatment of migraine in adults.
How Ajovy Works:
Migraine attacks involve activation of the trigeminovascular system — sensory nerve fibers around cranial blood vessels release CGRP and other neuropeptides, causing vasodilation, neurogenic inflammation, and pain signal transmission. CGRP is a master driver of this cascade.
Fremanezumab binds CGRP and prevents it from activating CGRP receptors on nerves and blood vessels — preventing the cascade of events that triggers migraine pain. The result is fewer migraine days per month, often with reduced severity and shorter duration of attacks when they do occur. Many patients see significant reduction in migraine frequency within 1–3 months of starting.
Form and use:
Ajovy is given as a subcutaneous injection. Two dosing options: 225 mg once monthly, OR 675 mg every 3 months (three 225 mg injections at the same visit). Available as prefilled syringe or autoinjector. Self-administered at home after training. No loading dose required.
Generic availability:
There is no biosimilar of Ajovy in the U.S. as of 2026. Other anti-CGRP monoclonal antibodies for migraine prevention include erenumab (Aimovig, anti-CGRP receptor, SC monthly), galcanezumab (Emgality, SC monthly), and eptinezumab (Vyepti, IV every 3 months). Oral CGRP receptor antagonists (gepants) for prevention include atogepant (Qulipta, daily) and rimegepant (Nurtec ODT, every other day; also for acute migraine). Older preventive options include beta-blockers (generic), topiramate (generic), amitriptyline (generic), and onabotulinumtoxinA (Botox, for chronic migraine).
Warnings:
Ajovy carries warnings for hypersensitivity reactions (including anaphylaxis — rare; can occur within hours to days of injection). Common side effects include injection-site reactions (pain, induration, erythema). Anti-CGRP monoclonal antibodies have a reassuring overall safety profile in clinical trials. Use during pregnancy: limited human data; case-by-case decision based on migraine severity and alternatives.
FAQ (Frequently Asked Questions)
How Much Does Ajovy Cost Without Insurance?
Ajovy costs approximately $700–$900 per monthly injection, or $2,100–$2,700 for the every-3-month 675 mg dose. Through AffordMyPrescriptions, qualifying patients receive Ajovy at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Quickly Will Ajovy Work?
Many patients see significant reduction in migraine days within the first month. Maximum benefit typically develops by month 3. If you don’t see meaningful benefit after 3 months of consistent dosing, your prescriber may consider switching to a different CGRP antibody or another preventive approach.
How Is Ajovy Different From Aimovig, Emgality, Or Vyepti?
All four are anti-CGRP/CGRP-receptor monoclonal antibodies for migraine prevention with similar overall effectiveness. Ajovy (fremanezumab) — anti-CGRP; SC monthly or quarterly. Aimovig (erenumab) — anti-CGRP receptor; SC monthly. Emgality (galcanezumab) — anti-CGRP; SC monthly. Vyepti (eptinezumab) — anti-CGRP; IV every 3 months. If one isn’t working or is poorly tolerated, switching to a different anti-CGRP antibody often helps.
Are CGRP Antibodies Better Than Older Preventives Like Topiramate?
CGRP antibodies are not necessarily more effective on average than older preventives (beta-blockers, topiramate, amitriptyline, valproate), but they are generally better tolerated — no daily oral pill, no weight gain (topiramate often causes weight loss; amitriptyline causes weight gain), no cognitive side effects (topiramate), and minimal systemic effects. They are typically prescribed after older preventives have failed or are contraindicated. Insurance often requires trial of generic preventives first
Can I Stop Taking My Acute Migraine Medications?
Not necessarily. Ajovy is a preventive medication — it reduces the frequency and severity of migraines but does not treat individual attacks. You should still have an acute treatment (triptan, gepant, NSAID, or other agent) for migraines that break through. As Ajovy reduces attack frequency, you may need acute medications less often. |
Can I Get Ajovy Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify, especially if you face specialty-tier copays. State Medicaid programs cover anti-CGRP antibodies in many states. The manufacturer’s commercial copay savings program is for commercially insured patients only.
What If My Application Is Denied?
If denied, we explore alternatives — switching to a different anti-CGRP antibody with its own PAP (Aimovig, Emgality, Vyepti), trying an oral CGRP receptor antagonist (Qulipta, Nurtec ODT), trying generic preventives (beta-blockers, topiramate, amitriptyline) which may be sufficient, the manufacturer’s copay program for commercially insured patients, or independent foundations such as the American Migraine Foundation, National Headache Foundation, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Ajovy, our team may be able to help you access assistance programs designed to make brand specialty CGRP migraine preventive therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.